Table 1 Red flag symptoms for potential autoimmune OCD as suggested by Endres et al. [30], their presence in the presented cases. See footnotes for suggestions for revised phrasing.

From: Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment

Red Flag

Case 1

Case 2

Case 3

Comment

1) (SUB)ACUTE ONSET OF OCD ( < 3 MONTHS)a

Yes

Yes

Maybe

Case 3: accentuation of OCD

2) TREATMENT RESISTANCE DESPITE GUIDELINE-BASED THERAPYb

Yes

Yes

Yes

 

3) ATYPICAL AGE OF ONSET (EARLY CHILDHOOD OR LATER ADULTHOOD)

No

No

No

 

4) ATYPICAL PRESENTATION OF OCD

Yes

Yes

Yes

Cases 1-2: severe hypersomnia; Cases 1-3: loss of function due to disproportionate cognitive deficits

5) ACCOMPANYING NEUROLOGICAL SIGNS: MOVEMENT DISORDER, FOCAL NEUROLOGICAL DEFICITS; NEW SEIZURES; NEW HEADACHE

No

Yes

Maybe

Case 2: choreatic movements; Case 3: seizures

6) AUTONOMIC DYSFUNCTION

No

No

No

 

7) ADVERSE RESPONSE TO ANTIPSYCOITICS

No

No

No

 

8) TEMPORAL ASSOCIATION OF ONSET WITH INFECTIONSc, d

No

Maybe

Maybe

Case 2-3: Self-reported, unverified

9) COMORBID AUTOIMMUNE DISEASE

No

Yes

Maybe

Case 2: Kawasaki’s disease, Case 3: suspected APS

10) COMORBID MALIGNANCIES (SUCH AS OVARIAN TERATOMA)

No

No

No

 

11) SUSPICIOUS ALTERTIONS IN INVESTIGATIONS:

Yes

Yes

Yes

See below

A) SERUM: AUTOANTIBODIES (NEURONAL, ANA)

No

Yes

No

Case 2: DRD-1 antibodies, (streptococcal abs. not tested)

B) EEG: SIGNS OF ENCEPHALOPATHY

-

No

No

 

C) MRI: BASAL GANGLIA/MESIOTEMPORAL HYPERINTENSITIES, INFLAMMATORY LESIONS

No

No

Maybe

Case 3: punctiform subcortical white matter changes

D) 18FDG-PET: ENCEPHALITIC PATTERNS WITH DISTURBED METABOLISM IN BASAL-GANGLIA, AND ALONG CORTICAL OR TEMPORAL REGIONS

Yes

-

No

Case 1: low uptake in anterior cingulum, right cerebellar hemisphere and medial of the posterior horn

E) CSF: PLEOCYTOSIS, OCBs, NEURONAL AUTOANTIBODIES, HIGH IgG INDICIES, DAMAGE MARKERS

Yes

No

Yes

Case 1: increased IgG index; Cases 1 + 3: OCBs

  1. APS antiphospholipid syndrome, ANA antinuclear antibodies, DRD-1 Dopamine receptor 1, CSF cerebrospinal fluid, OCBs CSF-specific oligoclonal bands
  2. Suggested revision (Comment):
  3. aa (sub)acute (<3 months) onset or accentuation of OCD.
  4. bAdd: Long-term (>2 years) inability to follow guidelines because of side-effects.
  5. cThe criterion is subjective and could potentially be improved by objective measures.
  6. dTemporal association of onset or clear exacerbation with infections, allergies or exacerbation of underlying immune disorder, and/or temporal association of amelioration with immune-modulatory treatment. (The criterion is hard to prove and distinguish from an undulating course of OCD).